🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Pet healthcare startup Dr. Doodley raises $3.3 Mn in pre-Series A

EntrackrEntrackr · 4d ago
Pet healthcare startup Dr. Doodley raises $3.3 Mn in pre-Series A
Medial

Pet healthcare startup Dr. Doodley raises $3.3 Mn in pre-Series A Pet healthcare startup Dr. Doodley has raised $3.3 million (Rs 30 crore) in a pre-Series A funding round. The round includes Rs 20 crore in equity and Rs 10 crore in debt, with the equity round led by V3 Ventures. Other participants include Campus Fund and Thackersey Family Office, along with angel investors such as Yatin Shah and Karan Bhagat, founders of 360 ONE Wealth, and Gautam Dalmia, managing director of Dalmia Bharat Group. The proceeds will be used to expand hospital capacity, strengthen clinical operations, and prepare for entry into other tier I cities. Founded in 2023 by Utsav Bisaria and Yash Jayprakash Ladda, Dr. Doodley operates a combined model of vet-at-home services and 24/7 multispecialty pet hospitals. The firm currently runs three hospitals in Bengaluru located in Jayanagar, Yelahanka, and Whitefield, and works with a team of around 35 veterinarians. Over the next 12 months, Dr. Doodley plans to expand to seven hospitals by opening four new facilities in Bellandur, Indiranagar, Rajajinagar, and North Bengaluru. During this period, the startup aims to treat more than 1,00,000 pets and increase its veterinary team to over 100 doctors. It also plans to launch 30-minute vet-at-home services and introduce a flat Rs 10,000 pricing model for surgeries across procedures. Dr. Doodley claims to have treated over 30,000 pets and conducted more than 1,000 surgeries in the past year.

Related News

Pet care startup Supertails scoops up $15 Mn in Series B

EntrackrEntrackr · 1y ago
Pet care startup Supertails scoops up $15 Mn in Series B
Medial

Full-stack pet care startup Supertails has raised Rs 125 crore (approximately $15 million) in a Series B funding round led by RPSG Capital Ventures and existing investors Fireside Ventures, Saama Capital, DSG Consumer Partners and Sauce VC. This funding will be deployed towards enabling business growth through the acquisition of new customers and investments in technology, along with the expansion of healthcare services including Supertails Pharmacy, the firm said in a press release. Supertails also plans to use the funds to foray into offline business strategy and build an omnichannel experience for consumers. In November 2022, the company raised $10 million in a Series A funding round in a mix of equity and debt led by Fireside Ventures. It has scooped up $27.5 million since its inception in June 2021. Founded by Varun Sadana, Aman Tekriwal, and Vineet Khanna, Supertails addresses the evolving needs of pet parents through their customised offerings. The Supertails app provides assortment of food, treats, accessories, and other pet essentials. Also Read: Amid pet care industry boom, PawPurrfect bets on convenience and healthcare To further support pet parents, the firm has introduced a pet pharmacy on its platform, becoming a full-stack platform offering pet supplies, online vet consultations, online behavior training, and a pet pharmacy. Supertails’ revenue from operations jumped 4.2X to Rs 33 crore during FY23 as compared to Rs 7.82 crore in FY22. As per startup data intelligence platform TheKredible, its losses surged 2.6X to Rs 30.6 crore in FY23 against Rs 11.65 crore in FY22. Supertails aims to double down on its growth and expansion plans to achieve an ARR of Rs 500 crore in the next two years. As per studies, the pet population in India stands at approximately 35 million, growing at a CAGR of 15% with a potential market size of $5 billion and Supertails aims to solidify its position as a leading player in the space. It competes with Heads Up For Tails, Goofy Tails, and JustDogs, among others. Heads Up For Tails emerged as the largest funded startup in this segment which raised $37 million in a Series A funding round led by Verlinvest and Peak XV Partners.

Healthcare edtech startup Virohan raises $7.5 Mn in ongoing Series B

EntrackrEntrackr · 1m ago
Healthcare edtech startup Virohan raises $7.5 Mn in ongoing Series B
Medial

Healthcare edtech startup Virohan raises $7.5 Mn in ongoing Series B Healthcare edtech startup Virohan has raised Rs 65 crore ($7.5 million) as part of its ongoing Series B funding round, led by Mynavi Corporation. The round also saw participation from Virohan’s existing investors including Blume Ventures, Bharat Inclusive Technologies Seed Fund, and Rebright Partners. The funding will accelerate Virohan’s path to profitability through product innovation, operational efficiencies, and strategic talent expansion, the company said in a press release. Virohan works with universities such as UPES, BBD University, CMR University, Assam Don Bosco University, and G.H. Raisoni University to offer undergraduate programs in allied healthcare, nursing, and healthcare management, and partners with healthcare companies including Lenskart, Medanta, Healthians, and Dr. Lal PathLabs to support student placements. The seven-year-old firm claims to have partnered with more than 20 higher education institutions, trained over 13,000 healthcare students, and worked with over 2,000 healthcare employers to support graduate employability. Virohan has raised over $25 million in funding so far. According to TheKredible, after the latest share allotment, Mynavi Corporation will hold a 3.83% stake in the company, while Blume Ventures will continue as the largest shareholder with a 16.16% holding. The company is yet to file its FY25 financials. In FY24, Virohan reported operating revenue of Rs 21 crore, up from Rs 10.65 crore in FY23, while its losses widened 18% year on year to Rs 22 crore.

Biomanufacturing startup Loopworm raises $3.25 Mn in pre-Series A round

EntrackrEntrackr · 7m ago
Biomanufacturing startup Loopworm raises $3.25 Mn in pre-Series A round
Medial

Biomanufacturing startup Loopworm raises $3.25 Mn in pre-Series A round Co-founded in 2019 by Ankit Alok Bagaria and Abhi Gawri, Loopworm is a biomanufacturing startup focused on sustainable protein production using farmed insects. Loopworm, a biomanufacturing company developing insect-derived proteins, has raised $3.25 million in a pre-Series A funding round. The round was co-led by WaterBridge Ventures, an existing investor, and ENRISSION INDIA CAPITAL, a Japanese venture capital firm. The Bengaluru-based company had previously raised $3.4 million in a seed funding round led by Omnivore and others. The proceeds will be allocated towards commercializing its recombinant protein production platform, targeting diagnostics, animal vaccines, and other applications with lower regulatory barriers, Loopworm said in a press release. Loopworm focuses on sustainable protein production using farmed insects. The company has commercialized insect-derived proteins and fats for aquaculture and pet nutrition and is now developing a novel reactor-free recombinant protein production platform using silkworms. Loopworm says it has developed a new approach to producing recombinant proteins—typically created by inserting genes into host organisms like yeast or bacteria to produce proteins of medical or industrial value. Its proprietary process bypasses this entirely by using silkworms as living factories to produce complex proteins, enabling faster, more cost-effective, and sustainable production. The company currently operates a state-of-the-art, 6,000-tonne-per-year insect processing facility in Bengaluru. It exports protein and oil from silkworms and other farmed insects to Europe, South America, and ASEAN countries for use in the aquaculture and pet food industries.

Exclusive: Heads Up For Tails to raise $25 Mn in Series B led by Apparel Group

EntrackrEntrackr · 1m ago
Exclusive: Heads Up For Tails to raise $25 Mn in Series B led by Apparel Group
Medial

Exclusive: Heads Up For Tails to raise $25 Mn in Series B led by Apparel Group Premium pet care startup Heads Up For Tails is in the final stages of raising $25 million in its Series B round, two people aware of the development told Entrackr. “The round is being led by Apparel Group India (AGI), the Indian arm of Dubai-based retail major Apparel Group, with participation from Malinea Pte Care Limited,” said one of the sources requesting anonymity. “The terms of the transaction have been finalised, and the money is set to flow in over the next few weeks,” said the source quoted above. “The firm has reached an annual revenue run rate (ARR) of Rs 400 crore.” Heads Up For Tails’ CEO Samarth Narang declined to comment on the story. According to sources, the company is planning an expansion into Dubai, which would mark its third major presence in the Asian region after India and Singapore. Heads Up For Tails is a premium D2C pet care brand offering food, treats, accessories, and grooming products. It sells through its own website, online marketplaces and a growing offline network, listing over 13,000 products from 250 plus brands, with a presence across 18 plus cities through 115 stores and 95 pet spas. According to data from startup intelligence platform TheKredible, the Gurugram-headquartered company has raised around $40 million prior to this round, including a $37 million Series A led by Peak XV Partners (formerly Sequoia Capital India) and Verlinvest in 2021. The latest round comes amid renewed investor interest in India’s pet care sector, spanning food, services, and healthcare. Gurugram-based pet healthcare platform Vetic is in process to raise $26 million in a Series C led by Bessemer Venture Partners, while Bengaluru-based Supertails is in talks to raise $15-20 million. On the nutrition side, Drools entered the unicorn club after global FMCG major Nestlé acquired a minority stake.

Dogsee Chew raises $8 Mn in Series B round

EntrackrEntrackr · 11m ago
Dogsee Chew raises $8 Mn in Series B round
Medial

Dogsee Chew raises $8 Mn in Series B round Natural pet treat brand Dogsee Chew has raised $8 million in its Series B round led by Ektha.com, with participation from promoters, Shivanssh Holdings, and Poddar Family Office. The brand has raised a total of $22 million in funding to date, including the current round. In January 2022, the startup raised $6.7 million in its Series A round, led by Mankind Pharma, along with existing investor Sixth Sense Ventures. The new funds will be used to scale up manufacturing capabilities by expanding existing factories and constructing a new production facility. The company also plans to strengthen its Amazon Global Selling strategy to drive growth in international markets and expand further into the United States and Canada in 2025. Founded in 2015 by husband-wife duo Bhupendra Khanal and Sneh Sharma, Dogsee Chew now has a presence in more than 30 countries. The startup claims to offer 100 percent vegetarian dog treats that are all-natural, human-grade, and protein-rich. "With the premiumization of the pet food category on the rise, the demand for our human-grade chews is exploding. This investment ensures we are well-prepared to meet this demand by scaling production and expanding our presence globally. To make our products more accessible, we also plan to open distribution hubs in key international markets, allowing our retail partners to seamlessly access Dogsee Chews with shorter lead times,” said Bhupendra Khanal. According to data intelligence platform TheKredible, Dogsee Chew’s revenue in FY24 stood at Rs 53.76 crore, compared to Rs 98 crore in FY23. The firm reported an almost flat loss of Rs 27.73 crore in the last financial year. The Bengaluru-based startup competes with brands such as Khanal Foods, Captain Zack, Fidele Dog Food, and others in the pet care segment.

Dr. Paws raises Rs 29.3 Cr in pre-Series A led by Chiratae Ventures

EntrackrEntrackr · 2m ago
Dr. Paws raises Rs 29.3 Cr in pre-Series A led by Chiratae Ventures
Medial

Bengaluru-based veterinary clinic chain Dr. Paws has raised Rs 29.3 crore ($3.5 million) in a pre-Series A funding round led by Chiratae Ventures. Existing investor Sauce also participated, along with venture debt from Trifecta Capital and Stride Ventures. The proceeds will be used to expand the clinic network in Bengaluru, where the company plans to add nine new clinics by 2026. Dr. Paws will also enter new markets including Hyderabad and Pune. It is also preparing to launch at-home veterinary services and private-label products across treats, supplements, and pet food. Founded by Udit Gadkary and Rakesh Santhapur, Dr. Paws operates veterinary clinics focused on consultations, surgeries, diagnostics, and preventive care. The firm currently runs three 24x7 clinics in Bengaluru, with two more under construction. Since launch, the company claims to have completed over 30,000 appointments and more than 800 surgeries. The clinics are reported to reach operating profitability within five months of launch. In parallel, Dr. Paws plans to invest in technology to improve clinical workflows, customer management, and internal training. It is also strengthening its leadership team for city-level and central operations.

Download the medial app to read full posts, comements and news.